Fir Tree Capital Management’s Ibere Pharmaceuticals IBER Stock Holding History

Fir Tree Capital Management’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-82,037	Closed	-$828K	–	360
2022 Q4	$828K	Sell	82,037 -163	-0.2%	-$1.63K	0.04%	300
2022 Q3	$815K	Hold	82,200	–	–	0.03%	400
2022 Q2	$806K	Hold	82,200	–	–	0.03%	426
2022 Q1	$806K	Hold	82,200	–	–	0.02%	432
2021 Q4	$799K	Hold	82,200	–	–	0.02%	429
2021 Q3	$797K	Hold	82,200	–	–	0.03%	337
2021 Q2	$795K	Buy	+82,200	New	+$800K	0.03%	321

Fir Tree Capital Management's IBER Position: Q1 2023 in Review

Fir Tree Capital Management sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 82,037 shares — an estimated $828K sold.

Fir Tree Capital Management first reported a position in IBER in Q2 2021 and held it in 7 quarters. The position peaked at $828K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Fir Tree Capital Management reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Fir Tree Capital Management sold 82,037 Ibere Pharmaceuticals shares in Q1 2023, an estimated $828K.
Fir Tree Capital Management first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 7 quarters.
Fir Tree Capital Management's Ibere Pharmaceuticals position peaked at $828K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Fir Tree Capital Management's 13F filing for Q1 2023, filed 15 May 2023.